Literature DB >> 12429554

Transport of cimetidine by flounder and human renal organic anion transporter 1.

Birgitta C Burckhardt1, Stefan Brai, Sonke Wallis, Wolfgang Krick, Natascha A Wolff, Gerhard Burckhardt.   

Abstract

The H(2)-receptor antagonist cimetidine is efficiently excreted by the kidneys. In vivo studies indicated an interaction of cimetidine not only with transporters for basolateral uptake of organic cations but also with those involved in excretion of organic anions. We therefore tested cimetidine as a possible substrate of the organic anion transporters cloned from winter flounder (fROAT) and from human kidney (hOAT1). Uptake of [(3)H]cimetidine into fROAT-expressing Xenopus laevis oocytes exceeded uptake into control oocytes. At -60-mV clamp potential, 1 mM cimetidine induced an inward current, which was smaller than that elicited by 0.1 mM PAH. Cimetidine concentrations exceeding 0.1 mM decreased PAH-induced inward currents, indicating interaction with the same transporter. At pH 6.6, no current was seen with 0.1 mM cimetidine, whereas at pH 8.6 a current was readily detectable, suggesting preferential translocation of uncharged cimetidine by fROAT. Oocytes expressing hOAT1 also showed [(3)H]cimetidine uptake. These data reveal cimetidine as a substrate for fROAT/hOAT1 and suggest that organic anion transporters contribute to cimetidine excretion in proximal tubules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429554     DOI: 10.1152/ajprenal.00290.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  10 in total

Review 1.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

2.  Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells.

Authors:  Abdul R Asif; Jürgen Steffgen; Maria Metten; R Willi Grunewald; Gerhard A Müller; Andrew Bahn; Gerhard Burckhardt; Yohannes Hagos
Journal:  Pflugers Arch       Date:  2004-12-10       Impact factor: 3.657

3.  Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.

Authors:  Cornelia B Landersdorfer; Carl M J Kirkpatrick; Martina Kinzig; Jürgen B Bulitta; Ulrike Holzgrabe; Ulrich Jaehde; Andreas Reiter; Kurt G Naber; Michael Rodamer; Fritz Sörgel
Journal:  Br J Clin Pharmacol       Date:  2010-02       Impact factor: 4.335

4.  Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney.

Authors:  Harunobu Tahara; Masayuki Shono; Hiroyuki Kusuhara; Hajime Kinoshita; Eiichi Fuse; Akira Takadate; Masaki Otagiri; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

5.  The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3.

Authors:  Amy G Aslamkhan; Deborah M Thompson; Jennifer L Perry; Kelly Bleasby; Natascha A Wolff; Scott Barros; David S Miller; John B Pritchard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-07-20       Impact factor: 3.619

6.  Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin.

Authors:  Adam L Vanwert; Chutima Srimaroeng; Douglas H Sweet
Journal:  Mol Pharmacol       Date:  2008-04-01       Impact factor: 4.436

7.  Renal secretion of the antiviral nucleoside analog AM188 is inhibited by probenecid, p-aminohippuric acid, and cimetidine in the isolated perfused rat kidney.

Authors:  Jiping Wang; Roger L Nation; Allan M Evans; Susan Cox
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 8.  How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.

Authors:  Douglas B Kell; Stephen G Oliver
Journal:  Front Pharmacol       Date:  2014-10-31       Impact factor: 5.810

Review 9.  Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.

Authors:  Elisa Lozano; Oscar Briz; Rocio I R Macias; Maria A Serrano; Jose J G Marin; Elisa Herraez
Journal:  J Pers Med       Date:  2018-04-16

Review 10.  Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.

Authors:  Miriam G Mooij; Anne T Nies; Catherijne A J Knibbe; Elke Schaeffeler; Dick Tibboel; Matthias Schwab; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.